Oxcarbazepine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Oxcarbazepine Price Trend, Index and Forecast
Track the latest insights on oxcarbazepine price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Oxcarbazepine Prices Outlook Q3 2025:
- USA: USD 161,138/MT
- Germany: USD 129,856/MT
- China: USD 143,332/MT
- Brazil: USD 146,793/MT
- Mexico: USD 120,853/MT
Oxcarbazepine Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the oxcarbazepine prices in the USA reached 161,138 USD/MT in September. Upward pressure reflected tighter validated output at several domestic producers and sustained demand from formulation plants. Buyers adjusted procurement timing to secure contracted volumes, while inland transport coordination and steady acceptance of imported grades helped maintain continuity amid elevated sourcing focus.
During the third quarter of 2025, the oxcarbazepine prices in Germany reached 129,856 USD/MT in September. Pricing moved lower as inbound scheduling from key overseas suppliers became more predictable, enabling distributors to replenish without resorting to premium spot purchases. European compliance routines and stable cross-border logistics supported orderly inventory rotation and moderated near-term commercial urgency among buyers.
During the third quarter of 2025, the oxcarbazepine prices in China reached 143,332 USD/MT in September. Prices rose as production pacing incorporated additional quality-verification steps that temporarily moderated throughput. Domestic formulation demand remained active, encouraging forward purchasing. Export scheduling and batch-release coordination continued to influence supplier allocation, prompting careful contract management by both local and international purchasers.
During the third quarter of 2025, the oxcarbazepine prices in Brazil reached 146,793 USD/MT in September. Prices strengthened amid tighter landed supply and planning adjustments by downstream manufacturers. Import-dependent distributors increased ordering discipline to manage customs timing and inland distribution constraints. The combination of steady local demand and planning for consistent delivery windows supported firmer procurement behavior across national supply chains.
During the third quarter of 2025, the oxcarbazepine prices in Mexico reached 120,853 USD/MT in September. Prices eased as distributors arranged more predictable inbound shipments and downstream formulators optimized inventory positions. Cross-border consolidation with neighboring distribution networks reduced reliance on urgent spot purchases. Documentation and customs handling rhythms allowed buyers to smooth intake, diminishing short-term premium sourcing pressure.
Oxcarbazepine Prices Outlook Q2 2025
- USA: USD 158,600/MT
- Germany: USD 131,300/MT
- China: USD 140,384/MT
- Brazil: USD 145,052/MT
- Mexico: USD 134,810/MT
During the second quarter of 2025, the oxcarbazepine prices in the USA reached 158,600 USD/MT in June. Prices edged higher as purchasers aligned procurement with anticipated manufacturing runs and coordinated documentation and transport flows. Distribution hubs emphasized reliable handover timelines, supporting uninterrupted supply into key production zones.
During the second quarter of 2025, the oxcarbazepine prices in Germany reached 131,300 USD/MT in June. Prices registered an increase as distributors structured intake around regulated inspection protocols and ensured stock adequacy for steady pharmaceutical usage. Inland transport channels provided predictable redistribution capabilities, reinforcing consistent operating conditions for buyers.
During the second quarter of 2025, the oxcarbazepine prices in China reached 140,384 USD/MT in June. Prices advanced as producers balanced batch-release rhythms with routine process verification, shaping timing for both domestic and export allocations. Downstream formulation facilities managed procurement with planned scheduling, integrating intake into stable manufacturing cycles.
During the second quarter of 2025, the oxcarbazepine prices in Brazil reached 145,052 USD/MT in June. Prices increased as importers structured arrivals to match regulated intake procedures and ongoing market demand. Coordination between port operations, customs workflows, and inland distribution supported disciplined purchasing aligned with pharmaceutical production requirements.
During the second quarter of 2025, the oxcarbazepine prices in Mexico reached 134,810 USD/MT in June. Procurement activity centered on organized stock rotation and predictable shipment timing, enabling formulation units to schedule material usage efficiently. Documentation and warehousing coordination allowed buyers to maintain steady access without relying on urgent replenishment.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the oxcarbazepine prices.
Europe Oxcarbazepine Price Trend
Q3 2025:
As per the oxcarbazepine price index, Europe experienced a downward trend, as reflected in Germany’s movement this period. Regional sourcing activities were shaped by regulated handling processes that govern pharmaceutical ingredients, influencing how distributors coordinated documentation and shipment pacing. Established cross-border transport networks supported consistent transit of materials into formulation hubs, allowing buyers to schedule replenishment with limited timing volatility. Improved accessibility from global production centers helped moderate procurement urgency, encouraging more measured intake planning across European markets.
Q2 2025:
Europe recorded an upward trend, consistent with rising prices in Germany. The region’s procurement cycles operated within harmonized regulatory and documentation structures that influence how pharmaceutical ingredients move between member states. Distributors aligned shipments with predictable inspection workflows, while inland logistics networks ensured reliable transfer into established formulation centers. Buyers maintained disciplined purchasing schedules that matched expected downstream usage, reflecting coordinated material planning across the European supply chain.
This analysis can be extended to include detailed oxcarbazepine price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Oxcarbazepine Price Trend
Q3 2025:
As per the oxcarbazepine price index, North America observed an upward trend, aligned with movement in the United States. Sourcing strategies were shaped by established regulatory oversight governing ingredient intake, which enabled predictable coordination between coastal gateways and inland manufacturing hubs. Distributors planned shipments around structured inspection and documentation procedures, ensuring steady availability for formulation activities. With transport corridors operating reliably, procurement remained focused on maintaining consistent stock levels rather than reactive replenishment.
Q2 2025:
The region registered an upward trend, reflecting the movement observed in the United States. Buyers coordinated procurement through organized port-handling and compliance systems that support regulated pharmaceutical ingredients, aligning deliveries with ongoing production cycles. Established cross-border distribution networks ensured dependable routing between major processing regions, while inventory planning emphasized steady intake to match downstream manufacturing requirements. These operational dynamics guided sourcing behavior across the region.
Specific oxcarbazepine historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Oxcarbazepine Price Trend
Q3 2025:
As per oxcarbazepine price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the oxcarbazepine pricing trends and oxcarbazepine price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on oxcarbazepine prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Oxcarbazepine Price Trend
Q3 2025:
Asia Pacific recorded an upward trend, consistent with movement seen in China. The region’s supply environment was influenced by the structured production and verification routines characteristic of major active-ingredient manufacturing hubs. Well-developed short-sea transport links supported predictable deliveries into markets such as South Korea and Japan, facilitating orderly intake by local pharmaceutical processors. Southeast Asian distributors, positioned close to principal production centers, coordinated procurement with routine export flows. These interconnected systems enabled consistent alignment between material availability and demand across the region.
Q2 2025:
Asia Pacific experienced an upward trend, aligned with rising prices in China. Production flows from major manufacturing hubs followed established verification and allocation processes, shaping availability for nearby markets. India’s extensive pharmaceutical sector maintained consistent ingredient uptake, while import-dependent economies coordinated procurement within reliable regulatory and port frameworks. Regional maritime routes supported predictable replenishment cycles, helping buyers synchronize intake with forecasted production needs.
This oxcarbazepine price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Oxcarbazepine Price Trend
Q3 2025:
Latin America observed mixed movements, with upward pricing in Brazil contrasted by a downward trend in Mexico. Import flows into major distribution points operated through established maritime corridors, enabling buyers to manage replenishment with greater predictability. Brazil’s role as a leading destination for pharmaceutical inputs supported organized positioning of materials for downstream formulators, while Mexico structured intake through integrated cross-border and ocean-freight channels. Procurement approaches across Southern Cone markets aligned with regional warehousing and inland-transport frameworks, guiding how ingredients were paced into manufacturing centers.
Q2 2025:
Latin America recorded an upward trend, consistent with the movement in Brazil. Regional procurement depended on structured maritime flows that supply downstream pharmaceutical processors across several markets. Brazil’s established distribution role ensured organized access for surrounding countries, while Mexico integrated domestic intake with regulated import systems. Southern Cone markets coordinated shipments through dependable deep-sea routes, using structured warehousing and transport capabilities to maintain continuity in material availability.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Oxcarbazepine Pricing Report, Market Analysis, and News
IMARC's latest publication, “Oxcarbazepine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the oxcarbazepine market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of oxcarbazepine at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed oxcarbazepine prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting oxcarbazepine pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Oxcarbazepine Industry Analysis
The global oxcarbazepine industry size reached USD 111.0 Million in 2025. By 2034, IMARC Group expects the market to reach USD 171.7 Million, at a projected CAGR of 4.96% during 2026-2034. Market expansion is supported by increasing neurological disorder diagnosis rates, steady uptake of antiepileptic therapies, and growing investment in pharmaceutical production capacity and distribution infrastructure across key global markets.
Latest News and Developments:
- June 2025: Lupin received tentative approval from the US FDA for its extended-release tablets containing oxcarbazepine. The company stated that the product would be manufactured at its Nagpur facility in India and noted that the approved ER oxcarbazepine tablets are bioequivalent to the reference listed drug (Oxtellar XR).
- February 2024: Camber Pharmaceuticals launched Oxcarbazepine Oral Suspension, USP, which are available in 250 mL bottles. The company released multiple strengths of the product to expand access to oxcarbazepine therapy for patients with partial-onset seizures.
Product Description
Oxcarbazepine is an anticonvulsant pharmaceutical compound used mainly for treating partial seizures. It is a keto analog of carbamazepine and is rapidly converted into its active metabolite, the monohydroxy derivative (MHD), which stabilizes neuronal membranes by blocking voltage-gated sodium channels. This reduces excessive neuronal firing and offers improved tolerability compared with older antiepileptic drugs.
The compound is produced through controlled multi-step organic synthesis and supplied in tablet, suspension, and extended-release forms. Its primary applications lie in epilepsy therapy, with additional off-label use in mood stabilization. Oxcarbazepine’s favorable pharmacokinetics, reduced enzyme induction, and reliable safety profile contribute to its broad adoption in modern neurological treatment.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Oxcarbazepine |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Oxcarbazepine Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of oxcarbazepine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting oxcarbazepine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The oxcarbazepine price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.